Welcome to NewJerseyLifeScience.com
NewJerseyLifeScience.com is part of a specialized network of state based biotechnology, medical device,
and life science sites that includes more than 3,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
More...
|
|
Learn About New Jersey's BioHistory
Why is there a biotechnology industry in New Jersey? Will the industry continue
to grow in New Jersey? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through New Jersey BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of New Jersey.
More NJ BioHistory...
|
Local News...
Free News Release Posting & Archiving Service
- Wyeth's major depressive disorder treatment Pristiq now available in U.S. pharmacies Wyeth Pharmaceuticals announced that PRISTIQ(TM), a new serotonin-norepinephrine reuptake inhibitor approved to treat adult patients with major depressive disorder, is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily.
Wyeth May 15, 2008
- PhotoMedex's XTRAC(R) excimer laser secures additional air time PhotoMedex announced that, due to increased interest from viewers, its XTRAC(R) excimer laser segment, which first aired on Wednesday, May 7th, on The Balancing Act, will also air on Friday, May 16 in addition to its originally scheduled air time of Monday, May 26th.
PhotoMedex, Inc. May 15, 2008
- FDA approves AstraZeneca’s Seroquel for maintenance treatment in bipolar disorder AstraZeneca announced that the U.S. Food and Drug Administration has approved SEROQUEL(R) (quetiapine fumarate) for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.
AstraZeneca May 14, 2008
- DuPont and Genencor create world-leading cellulosic ethanol company DuPont and Genencor announced an agreement to form DuPont Danisco Cellulosic Ethanol, a 50/50 global joint venture to develop and commercialize the leading, low-cost technology solution for the production of cellulosic ethanol to address a $75 billion global market opportunity.
Genencor May 14, 2008
- CuraGen repurchases $50.9 million of 2011 convertible debt for $43.2 million CuraGen announced the completion of a series of privately negotiated transactions with holders of the Company's 4% Convertible Subordinated Notes due February 2011 in which the Company retired a total of $50.9 million of the 2011 Notes for an aggregate purchase price of $43.2 million.
CuraGen Corporation May 14, 2008
More... | Submit News Release | National News
|